User:Mac/Agenda: Difference between revisions
< User:Mac
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== 2 Dec 2009 TODO == | == 2 Dec 2009 TODO == | ||
[[Mac/Agenda/2-Dec-2009|work completed]] | |||
* add GDx / PGx from SACGHS appendix and PGx paper to the case studies (~15?) | * add GDx / PGx from SACGHS appendix and PGx paper to the case studies (~15?) | ||
** Add OTC genetic tests to the list | ** Add OTC genetic tests to the list | ||
Revision as of 15:17, 15 December 2009
2 Dec 2009 TODO
- add GDx / PGx from SACGHS appendix and PGx paper to the case studies (~15?)
- Add OTC genetic tests to the list
- move to no.2, overall picture of kits
- write 1 paragraph / section of paper outline
- centralize answers to "do patents harm researchers?"
- complete field definition
- complete data, narratives, tools defn, build off of Ford report section
- get basic market stats / picture (just GDx)
- read last chapter's of Gene Cartels
- read SACGHS Report final draft
- back up the following statements with data (in particular, "But the vast majority of gene patents are obtained by universities and unlicensed, or by companies and unprosecuted.")
Duke team, Luigi interview
- come up w/ questions
- position on IVDMIAs
- use interview framework from EM
Identify people to ask about IVDMIA tests
- look at federal docket of comments in response to draft guideline
- ask the 5 OTC companies in interview